Methods of administering elagolix | Patent Publication Number 20180235963

US 20180235963 A1
Patent NumberUS 10537572 B2
Application Number15957469
Filled DateApr 19, 2018
Priority DateSep 1, 2015
Publication DateAug 23, 2018
Original AssigneeAbbvie Inc.
Current AssigneeAbbvie Inc.
Inventor/ApplicantsSandra L. Goss
Juki Wing-Keung Ng
Cheri E. Klein
Ahmed Salem
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.